After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
The market is fearful. Use that fear to buy, Cramer says.
Hedge fund billionaire Dan Loeb owns a greater than 17% stake in the newly public developer of a drugs including those for treatment of psoriasis.
These stocks look good as seasonal volatility sets in.
The drugmaker plans to submit the first targeted-blood-cancer drug to the U.S. by the end of the year.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.